Stock listing
Jaguar Health, Inc.
Selected listing: JAGX · NASDAQ · USD · US
Jaguar Health, Inc. (NASDAQ:JAGX), Health Technology. Latest release Oct 6, 2026: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal…
- Ticker
- NASDAQ:JAGX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Jaguar Health, Inc.
Jaguar Health, Inc. is a public company traded under the ticker JAGX in the American market. Jaguar Health aims to address unmet medical needs through its proprietary plant-based products.
Latest news from Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
October 5, 2026
Jaguar Health Announces a Special Stock Dividend
October 1, 2026
Jaguar Health Announces a Special Stock Dividend
October 1, 2026
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
September 28, 2026
Jaggaer Completes Acquisition of Ivoflow, Bringing AI-Powered Direct Materials Spend & Price Intelligence to Manufacturers
September 14, 2026
Events
Research Jaguar Health, Inc.
Alternate listings
JAGX:BOATS
US · USD
Alternate listing for Jaguar Health, Inc.; the primary context on this page is JAGX:NASDAQ.
1JA1:GETTEX
DE · EUR
Alternate listing for Jaguar Health, Inc.; the primary context on this page is JAGX:NASDAQ.
1JA1:FWB
DE · EUR
Alternate listing for Jaguar Health, Inc.; the primary context on this page is JAGX:NASDAQ.
1JA1:MUN
DE · EUR
Alternate listing for Jaguar Health, Inc.; the primary context on this page is JAGX:NASDAQ.
1JA:SWB
DE · EUR
Alternate listing for Jaguar Health, Inc.; the primary context on this page is JAGX:NASDAQ.